Skip to content

(+)-[C-11]-cis-N-benzyl-normetazocine: A selective ligand for sigma receptors in vivo

by John L. Musachio, Ursula Scheffel, Marigo Stathis, Hayden T. Ravert, William B. Mathews, Robert F. Dannals
Life Sciences ()
Get full text at journal


The in vivo biodistribution profile of the novel sigma (??) receptor ligand (+)-[C-11]-cis-N-benzyl-normetazocine ([C-11]-(+)-NBnNM) in mouse brain was examined. This radioligand displayed high brain uptake and a distribution consistent with the density of ?? receptors. Brain radioactivity levels peaked at 15 min postinjection and were largely maintained (ca. 80% of maximal values) up to 90 min postinjection. Pretreatment with several different ?? ligands (haloperidol, (+)-pentazocine, DuP 734, ifenprodil) effectively inhibited [C-11]-(+)-NBnNM binding in a dose-dependent manner in all brain regions. [C-11]-(+)-NBnNM binding sites were shown to be saturable with unlabeled (+)-NBnNM (ED50 = 0.02 mg/kg) and enantioselectively inhibited by the optical isomers of pentazocine. A blocking dose of the dopamine D2 antagonist spiperone (1 mg/kg) did not significantly inhibit [C-11]-(+)-NBnNM binding. Pretreatment with the phencyclidine (PCP) blocker 1-[1-(2-thienyl)cyclohexyl] piperidine (TCP) did not significantly alter total brain tissue radioactivity. Thus, [C-11]-(+)-NBnNM binds with high specificity and selectivity to ?? receptors in vivo and offers excellent potential to study ?? receptors in living human brain via positron emission tomography. ?? 1994.

Cite this document (BETA)

Authors on Mendeley

Readership Statistics

2 Readers on Mendeley
by Discipline
50% Biochemistry, Genetics and Molecular Biology
50% Medicine and Dentistry
by Academic Status
50% Researcher
50% Professor

Sign up today - FREE

Mendeley saves you time finding and organizing research. Learn more

  • All your research in one place
  • Add and import papers easily
  • Access it anywhere, anytime

Start using Mendeley in seconds!

Sign up & Download

Already have an account? Sign in